Seung Joo Kang

Dr. Seung Joo Kang

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
TKTae Han Kim
Tae Han Kim
IKIn-Ho Kim
In-Ho Kim
SKSeung Joo Kang
Seung Joo Kang
MCMiyoung Choi
Miyoung Choi
BKBaek-Hui Kim
Baek-Hui Kim
OTon behalf of The Development Working Groups for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team
on behalf of The Development Working Groups for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team
Kim TH, et al. J Gastric Cancer. 2023 Jan;23:e11. https://doi.org/10.5230/jgc.2023.23.e11

15 March 2021 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HJHye-Kyung Jung
Hye-Kyung Jung
SKSeung Joo Kang
Seung Joo Kang
YLYong Chan Lee
Yong Chan Lee
HYHyo-Joon Yang
Hyo-Joon Yang
SPSeon-Young Park
Seon-Young Park
URUpper Gastrointesinal Research
Upper Gastrointesinal Research
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, and Miyoung Choi, Korean College of Helicobacter and Upper Gastrointesinal Research. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl20288

1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
IKIn-Ho Kim
In-Ho Kim
SKSeung Joo Kang
Seung Joo Kang
WCWonyoung Choi
Wonyoung Choi
ASAn Na Seo
An Na Seo
BEBang Wool Eom
Bang Wool Eom
OTon behalf of The Development Working Group for the Korean Practice Guideline for Gastric Cancer 2024 Task Force Team
on behalf of The Development Working Group for the Korean Practice Guideline for Gastric Cancer 2024 Task Force Team
Kim IH, et al. J Gastric Cancer. 2025 Jan;25:e11. https://doi.org/10.5230/jgc.2025.25.e11

1 October 2018 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
JCJi Min Choi
Ji Min Choi
JYJong In Yang
Jong In Yang
SKSeung Joo Kang
Seung Joo Kang
YHYoo Min Han
Yoo Min Han
JLJooyoung Lee
Jooyoung Lee
YKYong Sung Kim
Yong Sung Kim
Ji Min Choi, Jong In Yang, Seung Joo Kang, Yoo Min Han, Jooyoung Lee, Changhyun Lee, Su Jin Chung, Dae Hyun Yoon, Boram Park, and Yong Sung Kim. J Neurogastroenterol Motil 2018;24:593-602. https://doi.org/10.5056/jnm18069

1 October 2013 in Atherosclerosis
Verified
Journal Article
Closed access
SKSeung Joo Kang
Seung Joo Kang
DKDonghee Kim
Donghee Kim
HPHyo Eun Park
Hyo Eun Park
GCGoh Eun Chung
Goh Eun Chung
SCSeung Ho Choi
Seung Ho Choi
SCSang-Heon Cho
Sang-Heon Cho

28 August 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SKSeung Joo Kang
Seung Joo Kang
BPBoram Park
Boram Park
CSCheol Min Shin
Cheol Min Shin
Background: Previous studies on the effect of Helicobacter pylori eradication on functional dyspepsia (FD) are conflicting. We performed a comprehensive meta-analysis on this issue according to region and prevalence of H. pylori. Methods: Randomized controlled trials (RCTs) evaluating the effect of eradication of H. pylori on functional dyspepsia up to December 2018 were searched through PubMed, EMBASE, and the Cochrane Library. Subgroup analyses by the outcome measure, region, and prevalence of H. pylori were performed. All data were analyzed with Review Manager 5.3. Results: Eighteen RCTs were included in our meta-analysis. Overall, the H. pylori eradication group showed significant improvement of symptoms compared with the control group (risk ratio (RR) = 1.18; 95% confidence interval (CI): 1.07–1.30, p < 0.01). There was moderate heterogeneity among studies (I2 = 34%) and the number needed to treat (NNT) was 15.0. Helicobacter pylori eradication improved dyspeptic symptoms both in low (<50%) and high (≥50%) H. pylori prevalence regions (RR = 1.21 and 1.17; 95% CI: 1.02–1.44 and 1.06–1.29, I2 = 49% and 5%, respectively.) In the analysis of studies from Asia, however, the effect of eradication on improvement of dyspepsia was not significant (RR = 1.14; 95% CI: 0.99–1.33, p = 0.08, I2 = 37%). Conclusion: Overall, H. pylori eradication provides significant improvement of symptoms in functional dyspepsia patients regardless of H. pylori prevalence. However, in the analysis of studies from Asia, the eradication did not significantly improve dyspeptic symptoms. In this region, eradication for dyspepsia can be individualized.